From: Chris Dilorio To: Subject: Fw: Formal appeal for denial covered action 2015-016/ Knight Capital TCR & Appendix Date: Wed, 16 Sep 2020 12:25:26 +0000 Attachments: KCG_Appendix_3-20_13_penultimate.docx; KCG_TCR_3-20-13-penultimate_draft.pdf; KCG_TCR_3-20-13-penultimate_draft.docx; KCG_Appendix_3-20_13_penultimate.pdf Janey, Schwarzman must be pretty close to the top of the SEC's "do not investigate" list. The latest Schwarzman/Blackstone orchestrated fraud and cover up: KODK Today, the KODK Board Member Jason New: Blackstone "independent" outside inquiry by the law firm Akin Gump is in https://www.kodak.com/content/products-brochures/Company/Report-to-the-Special-Committee- 09.15.2020.pdf "gaps" indeed The flowery New/BX cover up is chock FULL of gaps. "Introduction to Phlow" Phlow: the VA consortium receiving $350 mil in Government Covid funding to provide Trump pushed Covid Cure: hydroxychloroquine https://www.prnewswire.com/news-releases/phlow-corporation-awarded-354-million-hhsasprbarda-contract- to-manufacture-essential-medicines-in-shortage-301061648.html Phlow Corporation Awarded $354 Million HHS/ASPR/BARDA Contract to Manufacture Essential Medicines in Shortage - PR Newswire RICHMOND, Va., May 19, 2020 /PRNewswire/ -- Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing ... www.prnewswire.com Phlow already has/had a long standing relationship with Ampac Fine Chemicals EFTA00094212